A Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
1/16/2013

Alabama, Arizona, Arkansas, California, Colorado, District of Columbia, Florida, Georgia, Idaho, Illinois, Iowa, Kansas, Maryland, Massachusetts, Michigan, Minnesota, New York, Oregon, Pennsylvania, Tennessee, Texas, Utah, Wisconsin, Argentina, Austria, Brazil, Bulgaria, Canada, China, Columbia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Romania, Russia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, Turkey, United Kingdom, Venezuela. clinicaltrials.gov

Related Summaries